Loading...

Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis

BACKGROUND: This case is the first report describing rapid, successful treatment of severe atopic dermatitis (AD) and comorbid type-2 inflammatory diseases in the same patient, with dupilumab treatment, with no side-effects. CASE PRESENTATION: We report on effects of dupilumab in a patient with seve...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Mol Allergy
Main Authors: Nettis, Eustachio, Masciopinto, Lucia, Di Leo, Elisabetta, De Candia, Nicola, Albanesi, Marcello, Di Bona, Danilo, Quaranta, Nicola, Macchia, Luigi
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8207639/
https://ncbi.nlm.nih.gov/pubmed/34134707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-021-00144-x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!